GWAS |
- Alzheimer's disease ( 19734902 19734903 21627779 31473137)
- Alzheimer's disease (late onset) ( 21460841 30617256 24162737 28714976)
- Alzheimer's disease in APOE e4+ carriers ( 25778476)
- Alzheimer's disease in APOE e4- carriers ( 25778476)
- Alzheimer's disease or family history of Alzheimer's disease ( 33589840 30617256)
- Alzheimer's disease or fasting insulin levels (pleiotropy) ( 30805717)
- Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy) ( 31835028)
- Autism spectrum disorder or schizophrenia ( 28540026)
- Family history of Alzheimer's disease ( 30617256)
- Lung adenocarcinoma ( 28604730)
- Lung cancer in ever smokers ( 28604730)
- Panic disorder ( 19165232)
- Refractive error ( 32231278)
- Schizophrenia ( 25056061 29483656)
- Smoking behaviour (cigarettes smoked per day) ( 31089300)
- Smoking initiation ( 33082346)
- Smoking status (ever vs never smokers) ( 30643258)
- Spherical equivalent or myopia (age of diagnosis) ( 29808027)
|
- Blood protein levels ( 30072576)
- Body mass index (alcohol intake interaction) ( 23192594)
- Brain morphology (min-P) ( 32665545)
- Brain morphology (MOSTest) ( 32665545)
- Cerebrospinal fluid AB1-42 levels ( 28247064)
- Cortical surface area (min-P) ( 32665545)
- Cortical surface area (MOSTest) ( 32665545)
- Cortical thickness (min-P) ( 32665545)
- Cortical thickness (MOSTest) ( 32665545)
- General risk tolerance (MTAG) ( 30643258)
- Number of sexual partners ( 30643258)
- Subcortical volume (min-P) ( 32665545)
- Subcortical volume (MOSTest) ( 32665545)
- Type 2 diabetes nephropathy ( 30566433)
- Urinary metabolite levels in chronic kidney disease ( 31959995)
|